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Cancer Supportive and Survivorship Care 
in Singapore: Current Challenges and 
Future Outlook
INTRODUCTION
Cancer is the leading cause of morbidity and 
mortality in Singapore. The number of new can-
cer diagnoses (for all cancer types) has increased 
from 45,799 in 2003 to 2007 to 61,522 in 2010 
to 2014.1 The three most common cancer types 
in men are colorectal, lung, and prostate can-
cers, whereas the most common cancer types in 
women are breast, colorectal, and lung cancers.2 
As a result of advancements in cancer thera-
peutics and early detection, the overall survival 
rates for all cancer types have improved signifi-
cantly. The 5-year age-standardized observed 
survival rates for breast and colorectal cancers 
have increased from 67.5% and 45.9% during 
the period of 2005 to 2009 to 70.5% and 50.7% 
during the period of 2010 to 2014, respectively.1 
However, survivors of cancer experience a myr-
iad of health issues related directly to the cancer 
itself, pre-existing comorbidities, and antican-
cer therapies, all of which can potentially com-
promise their health-related quality of life and 
culminate in functional impairment at significant 
economic, emotional, and social costs.3-6
In view of the unique and unmet needs of sur-
vivors of cancer, the Institute of Medicine has 
emphasized how survivorship programs are 
essential to address the supportive and survivor-
ship care needs of survivors of cancer.7 Although 
supportive care centers on the management of 
health problems related to cancer and its treat-
ment, survivorship care focuses on helping sur-
vivors of cancer re-establish holistic normalcy 
after completion of cancer treatment. Survivor-
ship care also encompasses management of the 
financial, psychological, and social impacts of 
cancer diagnoses and treatments on survivors 
of cancer and their family members and care-
givers.6,8 Today, cancer supportive and survivor-
ship care is recognized as one of the pillars of 
oncology care, and this is evident by the growing 
research efforts in this area, as well as the num-
ber of cancer institutes that have incorporated 
supportive and survivorship care programs and 
services.
Despite being a relatively young nation, Singapore has established itself as a leading multifaceted 
medical hub, both regionally and globally. Although Singapore continues to pursue excellence in 
oncology care, cancer supportive care and survivorship care remain in the infancy stage. In an 
effort to advance this important aspect of oncology care in Singapore, the first cancer supportive 
and survivorship care forum was held in December 2016, involving 74 oncology practitioners. The 
primary goals of this forum were to raise awareness of the importance of cancer supportive and 
survivorship care and to provide a platform for oncology practitioners of diverse backgrounds to 
converge and address the challenges associated with the delivery of cancer supportive and survi-
vorship care in Singapore. Key challenges identified during this forum included, but were not lim-
ited to, care fragmentation in an oncologist-centric model of care, poor integration of allied health 
and rehabilitation services, passive engagement of community partners, lack of specialized skill 
sets and knowledge in supportive and survivorship care, and patient-related barriers such as poor 
health literacy. The survivorship care model commonly used in Singapore places an imbalanced 
emphasis on surveillance for cancer recurrence and second primary cancers, with little attention 
given to the supportive and survivorship needs of the survivors. In summary, these challenges 
set the stage for the development and use of a more survivor-centric model, one that focuses not 
only on cancer surveillance, but also on the broad and unique physical and psychosocial needs 
of survivors of cancer in Singapore.
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In Singapore, cancer care is provided by both 
public tertiary institutes and private cancer cen-
ters. Within the public health system, health 
care is kept affordable through a financing 
system that relies heavily on individual respon-
sibility and government subsidies, achieved 
through compulsory individual medical savings 
and insurance schemes. At present, the major-
ity of cancer care is provided through publicly 
funded national cancer centers, and some of 
these centers have developed cancer survivor-
ship care programs, although they are mostly 
small in scale and may only address specific 
health issues in niche populations. Examples 
would include speech therapy–led rehabilitation 
programs to address treatment-related speech 
and swallowing issues faced by patients with 
head and neck cancers and small-scale nurse-
led patient navigation programs for patients with 
cancer with significant comorbidities and social 
challenges. Although commendable, these pro-
grams do not address the greater unmet sur-
vivorship care needs of all survivors of cancer. 
This is compounded by the fragmented and ad 
hoc nature of survivorship care as a result of the 
lack of awareness and integration of survivorship 
care into routine oncologic care and the short-
age of health care professionals with supportive 
and survivorship care expertise. Change is des-
perately needed at both national and institutional 
levels to meet the survivorship care needs of the 
increasing numbers of survivors of cancer in 
Singapore.
SINGAPORE’S FIRST CANCER SUPPORTIVE AND 
SURVIVORSHIP CARE FORUM
On December 3, 2016, the first cancer sup-
portive and survivorship care forum was held 
in Singapore; the forum involved 74 oncology 
practitioners, including oncologists, nurses, 
pharmacists, and other allied health care pro-
fessionals. The primary goals of this forum were 
to raise awareness of the importance of cancer 
supportive and survivorship care and to provide 
a platform for oncology practitioners of diverse 
backgrounds to converge and address the chal-
lenges associated with the delivery of cancer 
supportive and survivorship care in Singapore. 
This article provides a summary of the forum 
and an outlook of Singapore’s future cancer sup-
portive and survivorship care landscape.
CURRENT CHALLENGES IN SINGAPORE'S 
SUPPORTIVE AND SURVIVORSHIP CARE 
LANDSCAPE
Health Care System
In Singapore, the majority of survivors of cancer 
consult their oncologists, who may be based at 
various cancer centers, for their supportive and 
survivorship care needs, with cancer surveil-
lance being the primary focus of survivorship 
care. With the increasing cancer incidence 
and survival rates, the existing infrastructure in 
Singapore cannot meet the increasing demand 
for cancer supportive and survivorship care 
services in a sustainable manner. The current 
oncologist-centric survivorship landscape is 
in stark contrast with survivorship care mod-
els in the developed countries of North Amer-
ica and Europe, where primary care providers 
are actively involved in a shared-care model of 
survivorship care delivery.9 Such a shared-care 
model is shown to improve survivors’ quality of 
life and care satisfaction, reduce costs, increase 
continuity of care, and reduce the burden on 
oncologists and tertiary health care institutes.10-14 
Historically, cancer has always been a disease 
managed in tertiary health care settings in Sin-
gapore, and currently, there is a lack of training 
or robust professional development courses to 
allow primary health care providers to develop 
skill sets in cancer survivorship. Without the 
involvement of primary health care providers 
in cancer survivorship care, community care 
coordination for survivors of cancer, especially 
those with complex comorbidities, is lacking. 
In recent years, there have been increasing 
efforts to transition care from tertiary institutes 
to the community by empowering and engaging 
community-based family physicians; however, it 
must be emphasized that Singapore’s initiative 
for one family physician for every Singaporean is 
still in the infancy stage.15,16
Oncology Practitioners and Specialty Care 
Providers
Oncology practitioners often indicate that they 
are not equipped with the appropriate skills and 
knowledge to identify and manage some of the 
lesser known supportive and survivorship care 
issues.17 This problem is compounded by the 
lack of evidence-based management strate-
gies for certain chronic and late adverse effects 
such as cognitive impairment and peripheral 
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neuropathy. Although numerous guidelines have 
been published by the National Comprehensive 
Cancer Network, the Multinational Association of 
Supportive Care in Cancer, and ASCO to address 
management of survivorship issues, many rec-
ommendations in these guidelines are based on 
expert opinions and include therapies that are 
not readily available in Singapore.18-21
The provision of excellent supportive and survi-
vorship care to patients with cancer and survi-
vors requires a multidisciplinary approach that 
encompasses other health care disciplines, such 
as rehabilitation, nursing, and allied health. How-
ever, the involvement of these specialty care 
providers is largely ad hoc in nature and not 
integrated into routine oncologic care, resulting 
in fragmentation and suboptimal provision of 
supportive and survivorship care to survivors of 
cancer in Singapore, especially those with com-
plex survivorship issues impacting quality of life.
Survivors
The multiracial and multicultural population in 
Singapore poses unique patient-specific chal-
lenges that must be addressed to allow for 
the delivery of successful cancer supportive 
and survivorship care. First, as a result of cul-
tural and religious sensitivities, survivors have 
expressed discomfort and unwillingness to dis-
cuss sensitive survivorship health issues such 
as sexuality and fertility with their oncology 
practitioners, which hampers the provision of 
support and services for such issues. Second, 
despite a reasonably high level of general health 
literacy among Singaporeans, the adequacy of 
cancer-related health literacy is unknown, with 
oncology providers generally questioning the 
ability of survivors of cancer to be self-aware and 
self-manage their cancer survivorship issues.17 
Third, survivors of cancer may turn to unorth-
odox alternative treatments to manage their 
health problems, particularly when the use of 
complementary and alternative medicines and 
traditional Chinese medicines is highly prevalent 
in Singapore.22 Although anecdotal benefits are 
occasionally reported, many of these therapies 
are not proven to be effective and may actually 
be harmful to survivors. Fourth, despite the ben-
efits and importance of community care coordi-
nation through primary care providers, survivors 
are reluctant to involve them in their support-
ive and survivorship care journey, preferring to 
receive ongoing care at tertiary centers. Finally, 
the financial burden from treatment and con-
sultation fees may deter patients from attending 
follow-up appointments or complying with rec-
ommended treatments.23
PROPOSED SURVIVORSHIP CARE MODEL IN 
SINGAPORE
The commonly used survivorship care model in 
Singapore places an imbalanced emphasis on 
surveillance for cancer recurrence and second 
primary cancers, with little attention given to the 
rehabilitative needs of survivors of cancer after 
diagnosis and treatment. The challenges laid 
out earlier set the stage for a shift toward a more 
survivor-centric model, one that focuses not only 
on cancer surveillance, but also on the broad 
and unique physical and psychosocial needs of 
survivors of cancer in Singapore.
Participants in the forum identified several prin-
ciples as vital for the optimization of survivorship 
care in Singapore. The principles are briefly 
classified as follows: Survivorship care should 
be survivor centered, consist of integrated and 
coordinated care, promote wellness, be acces-
sible and equitable, and be research driven and 
evidence based.
1. Survivor-centered care: The model needs 
to be relevant and individualized to the 
needs of survivors of cancer at all stages 
of their survivorship journeys. In addition, 
survivors of cancer should be engaged 
and empowered to be active partners in 
their individual survivorship journeys.
2. Integrated and coordinated care: Cancer 
supportive and survivorship care should 
be integrated into routine oncologic care. 
Patients and survivors should have access 
to cancer supportive and survivorship care 
services across both tertiary and com-
munity health care settings. The health 
care team should assume responsibility 
for planning, providing, and coordinating 
various clinical services across the con-
tinuum of survivorship care. This will 
facilitate efficient and effective com-
munication between all tertiary and com-
munity health care professionals involved. 
Integrated and coordinated care would 
allow survivors of cancer to receive the 
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right type of care at the right time and in 
the right environment.
3. Promotion of wellness: With mounting 
evidence demonstrating the health bene-
fits of lifestyle interventions, cancer sur-
vivorship care must include measures 
to holistically improve the state of health 
of patients with cancer and survivors. 
Such examples include education and 
provision of community-based programs 
to encourage healthy lifestyle behaviors 
and self-monitoring and preventative care 
to maintain an optimal state of health.
4. Research-driven and evidence-based 
practices: To advance cancer supportive 
and survivorship care, a robust research 
infrastructure should be incorporated 
seamlessly into the survivorship model. 
This infrastructure should promote and 
facilitate research initiatives that address 
pertinent clinical problems, with an aim 
to develop evidence-based management 
strategies for cancer supportive and sur-
vivorship care.
5. Accessible and equitable care: Any sur-
vivor of cancer should be able to access 
supportive and survivorship care services 
at any point during his or her cancer 
journey. Increasing health care costs have 
resulted in an increased financial burden 
to survivors and their families. Thus, sup-
portive and survivorship care should be 
subsidized through strategic partnerships 
with governmental, commercial, and phil-
anthropic organizations.
On the basis of the aforementioned recommen-
dations, the proposed survivorship care model 
in Singapore should encompass the following 
elements (Fig 1).
1. Dedicated and integrated multidisciplinary 
survivorship care teams: The survivorship 
team is multidisciplinary in nature, pur-
posefully developed, and integrated into 
routine oncologic care. It involves both 
medical and paramedical staff with exper-
tise to not only manage the myriad of 
health and psychosocial issues faced 
by survivors of cancer, but also develop 
educational and research initiatives and 
drive institutional and governmental chan-
ges to advance the field of cancer sup-
portive and survivorship care in Singapore. 
Examples of disciplines involved in such 
a team include, but are not limited to, 
oncology, rehabilitative medicine, nursing, 
physical therapy, pharmacy, dietetics, 
and psychosocial oncology. These teams 
should also be present across both tertiary 
and community care settings to deliver 
survivorship care throughout the survivor-
ship continuum.
2. Localized cancer survivorship guidelines: 
Although international cancer survivorship 
guidelines have been developed by major 
organizations, these have to be localized 
to the health care and sociocultural needs 
and subtleties of an Asian nation such as 
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Fig 1. Proposed survi-
vorship care model and 
required elements.
Singapore. Guidelines can be translated 
to care pathways that can equip health 
care providers to provide evidence-based 
and cost-effective cancer survivorship 
care. An example is the standardization 
of care pathways for common treatment-
related toxicities, such as fatigue, cognitive 
impairment, peripheral neuropathy, end-
ocrine therapy–specific toxicities (eg, hot 
flashes), and musculoskeletal symptoms.
3. Community partnerships: The community 
environment is beneficial for survivors for 
several reasons. First, it is beneficial for 
survivors to recuperate and receive care in 
familiar environments, which in turn may 
promote psychological recovery as they 
transition from institution-based acute 
care. Second, community-based survivorship 
care provides an excellent conduit for 
health and wellness promotion. Finally, the 
transition of survivors to community-based 
care will substantially reduce the workload 
of oncology health care providers in tertiary 
institutions, allowing for more efficient 
and effective use of health care resources. 
Community health care providers, such as 
general practitioners or family medicine 
phy sicians, nurses, pharmacists, and phy-
sical therapists, should collaborate with 
tertiary oncology health care providers 
and community partner organizations to 
optimize supportive and survivorship care. 
An example of a community partner organi-
zation is the Singapore Cancer Society, 
which not only provides means-based 
financial support to patients with cancer, 
but also has recently taken major steps 
toward expanding cancer survivorship care 
through the establishment of a community 
cancer rehabilitation center to address 
the needs of survivors of cancer and their 
caregivers.
4. Robust adaptive patient assessment 
program: This would entail detailed initial 
assessments, including health literacy, 
treatments (planned or completed), existing 
unmet or possible future supportive care 
or survivorship needs, and psychosocial 
backgrounds, to guide survivorship care 
planning. This would be followed by 
long itudinal assessments throughout the 
survivor’s journey, allowing for the detection 
of new or ongoing health issues to be 
addressed. In addition, such assessments 
would also allow the provision of inter-
ventions and resources to survivors of 
cancer that are stratified to the complexity 
and severity of their health issues.
5. Mandatory survivorship care plan: Every 
survivor of cancer must be given a 
survivorship care plan at the completion 
of their acute cancer care, and this plan 
should be compatible with the individual’s 
health literacy and accessible to all health 
care professionals and caregivers. The 
survivorship care plan empowers survivors 
and their caregivers to take charge of their 
survivorship care needs and facilitates 
the transfer of crucial information to other 
health care providers involved in their 
survivorship journey. This care plan should 
include information such as treatment 
history, planned future treatments and 
follow-ups, any current or future supportive 
and survivorship care needs, respective 
management plans, recommended lifestyle 
changes, and other information related to 
the care of the survivor.
6. Education and empowerment of survivors 
of cancer: Survivors of cancer must be 
regarded as active partners in survivorship 
care and be provided access to survivorship 
care resources adapted to their spoken 
language and health literacy levels.
7. Sustainable resources and affordability: 
Because of the increasing health care 
costs and constantly evolving health care 
resource allocations, survivorship care in 
Singapore needs to be financially sus-
tainable for survivors, health care insti-
tutions, and providers. Survivorship care 
teams can assist survivors in navigating 
and optimizing their access to the complex 
array of governmental and volunteer 
welfare organization financial subsidies 
and bene fits. In addition, collaboration 
between health care institutions and pro-
viders, governmental bodies, and volunteer 
wel fare organizations is required to ensure 
adequate resources (such as manpower 
allocation and governmental subventions) 
are allocated to cancer survivorship care in 
a sustainable manner.
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8. Care coordination through patient navigators: 
Successful survivorship care cannot be 
achieved without a dedicated care coor-
dination service for survivors. It is well 
known that cancer care is becoming 
increasingly complex and multidisciplinary 
in nature, and when combined with a 
complex health care and funding system, 
as exists in Singapore, cancer care can 
be confusing, resulting in suboptimal care 
among survivors. Patient navigators could 
guide patients and survivors through their 
treatment and survivorship journeys by 
coordinating various aspects of care such 
as appointments, optimizing resources 
available to the patients and survivors, and 
providing oncology-specific care advice. 
Such a service also ensures that care needs 
are met and no survivor is lost in transition. 
The need for care coordination is equally 
important in tertiary and community care 
settings because care needs do not dec-
rease, but will change over time as survivors 
move through the survivorship continuum.
9. Information flow system: For coordinated 
care to be achieved, a continuous and 
efficient information flow system between 
community providers and specialists is 
needed. The information flow system could 
be in the form of a portal that allows remote 
access to patients’ health care data, com-
munication among various health care 
providers across the health care system, 
and scheduling of patient appointments.
10. Research: A survivorship care model should 
be combined with a robust research infra-
structure to provide cutting-edge therapies 
in supportive and survivorship care. With a 
research infrastructure in place, clinical trials 
and research can be conducted to advance 
understanding and develop new interventions 
and programs. In addition, robust and high-
quality data should be collected seamlessly 
to evaluate the effectiveness of current and 
new interventions and programs. A key 
area of focus would be on the develop-
ment of interventions to manage poorly 
understood supportive and survivorship 
issues, such as chemotherapy-associated 
neuropathy, cancer-related fatigue, and 
cognitive impairment.
CONCLUSION AND FUTURE DIRECTIONS
Cancer survivorship care is still in its infancy in 
Singapore. With an aging population, increasing 
cancer survival rates, and increasingly unmet 
cancer supportive and survivorship care needs, 
the need for effective cancer supportive and 
survivorship care services has never been more 
urgent. These services cannot exist in isolation, 
but should be framed within a model of care 
that complements both the unique needs of 
Singapore’s survivors of cancer as well as Sin-
gapore’s health care infrastructure. Singapore’s 
ongoing shift toward developing a community- 
based health care system is a necessary step in 
the provision of future community-based can-
cer survivorship services. Core working groups 
across tertiary and community health care pro-
viders and institutions, as well as collaboration 
with governmental and volunteer welfare orga-
nizations, are necessary to advance the field of 
supportive and survivorship care for the benefit 
of survivors of cancer and their families. These 
working groups and collaborations can in turn 
lead to the development of evidence-based 
cancer supportive and survivorship care best 
practices for Singapore, improved access to clin-
ical services, and the formation of collaborative 
research networks to advance cancer support-
ive and survivorship care locally, regionally, and 
internationally.
Through this forum, we have taken initial steps 
to raise awareness, discuss challenges, and 
unite various stakeholders in cancer supportive 
and survivorship care in Singapore. In response, 
we have developed a supportive and survivor-
ship care model and a set of guiding principles 
that will serve as the blueprint for Singapore’s 
future cancer supportive and survivorship care 
paradigm. This is the start of a nationwide move-
ment to ultimately provide holistic and integrated 
care for survivors of cancer and to transform 
Singapore into a regional and international 
center of excellence in cancer supportive and 
survivorship care.
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